ROCKWELL MEDICAL, INC. Estimated Litigation Liability, Current
ROCKWELL MEDICAL, INC. (RMTI) had Estimated Litigation Liability, Current of $0 as of 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LitigationReserveCurrent · last filed 2021-03-31
- 2020-12-31: Estimated Litigation Liability, Current $0.00.
- 2020-09-30: Estimated Litigation Liability, Current $0.00.
- 2020-06-30: Estimated Litigation Liability, Current $0.00.
- 2020-03-31: Estimated Litigation Liability, Current $57.00K.
| Period end | Estimated Litigation Liability, Current |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-31 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-09 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
| 2020-03-31 | $57.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $104.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $270.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $430.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $166.67K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $416.67K 10-K · filed 2020-03-17 |
| 2018-09-30 | $666.67K 10-Q · filed 2018-11-09 |
| 2018-08-07 | $1.50M 10-K · filed 2019-03-18 |
| 2018-06-30 | $1.53M 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |